Feature
Blurring the boundaries between living and non-living with new PhD programme
A new PhD programme will focus on cellular bionics - the science of fusing the living and non-living, which will transform bioengineering and design.
Imperial branches out to develop synthetic biology in East Africa
Synthetic biology experts from Imperial College London headed to East Africa to help identify where the field could have a life-changing impact.
2
The 10 most popular Imperial news stories of 2016
It's been a year packed with news at Imperial, from headline-grabbing research findings, to stunning staff and student achievements.
8 times Imperial blew your mind in 2016
Imperial researchers stole the headlines in 2016 with some game-changing discoveries.
Imperial students crowned iGEM Champions
An Imperial team have been crowned winners of the iGEM competition - an international student prize for synthetic biology.
A new way to create synthetic proteins could lead to more flexible designs
Building up proteins from scratch, rather than piecing together fragments of existing proteins, could make designing new nanomaterials easier.
Three 'risky' research projects get a boost from Imperial-MIT joint award
The first awards from the MIT-Imperial College London Seed Fund have been given to early-stage breakthrough projects spanning the two institutions.
SynbiCITE leads UKTI trade mission to SynBioBeta San Francisco 2015
SynbiCITE is leading a UKTI trade mission to synthetic biology conference SynBioBeta San Francisco 2015
SMART Synthetic Biology
SynbiCITE partner Visbion are delighted to have been chosen as the recipient of an Innovate UK SMART initiative for a new synthetic biology project.
SynbiCITE funds new vaccine for Chlamydia
We are delighted to announce that Prokarium, a biotechnology company developing transformational oral vaccines, will receive funding from SynbiCITE.
